Inhibition of the neuronal uptake of 5-hydroxytryptamine and noradrenaline in rat brain by (Z)- and (E)-3-(4-bromophenyl)-N,N-dimethyl-3-(3-pyridyl) allylamines and their secondary analogues.
D000499:Allylamine / Q000031:analogs & derivatives* / Q000378:metabolism / Q000494:pharmacology; D000588:Amines / Q000031:analogs & derivatives*; D000818:Animals; D001921:Brain / Q000166:cytology / Q000378:metabolism*; D003342:Corpus Striatum / Q000166:cytology / Q000378:metabolism; D003864:Depression, Chemical; D004298:Dopamine / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D007031:Hypothalamus / Q000166:cytology / Q000378:metabolism; D066298:In Vitro Techniques; D007536:Isomerism; D008297:Male; D009474:Neurons / Q000187:drug effects / Q000378:metabolism*; D009638:Norepinephrine / Q000378:metabolism*; D011725:Pyridines / Q000378:metabolism / Q000494:pharmacology*; D051381:Rats; D012701:Serotonin / Q000378:metabolism*; D013997:Time Factors
D000588:Amines; D011725:Pyridines; D012701:Serotonin; D000499:Allylamine; D004298:Dopamine; D009638:Norepinephrine